Le Lézard
Classified in: Health
Subjects: AWD, NPT

AlloSource Awards Dr. Kevin Shea The Annual Dr. Steven Gitelis Inspiration Award


CENTENNIAL, Colo., July 17, 2018 /PRNewswire-USNewswire/ -- AlloSource, one of the largest nonprofit cellular and tissue networks in the country, offering life-saving and life-enhancing solutions in orthopedic, spine, burn and wound procedures to help restore patient health and mobility, today announced that it will award Dr. Kevin Shea with its second annual Dr. Steven Gitelis Inspiration Award. The award honors a doctor or clinician that inspires AlloSource through his or her work in treating patients with allografts.

Dr. Shea recently joined the Stanford University School of Medicine as a professor of orthopedic surgery and also serves as director of the Stanford Children's Health Sports Medicine Program. He specializes in the treatment of knee ligament and cartilage injuries, osteochondritis dissecans (OCD), fractures, and pediatric trauma and is one of the founders of The ROCK Group, an organization dedicated to researching OCD and improving its treatment methods.

"I am honored to receive this award," said Dr. Shea.  "I look forward to continued advancements in the field of orthopedics."

Dr. Shea has been crucial in coordinating efforts between The ROCK Group and AlloSource in research on OCD and other pediatric orthopedic conditions.  Dr. Shea works tirelessly to find unique uses for donated allograft material for pediatric orthopedic applications. In 2018, Dr. Shea was a recipient of the American Academy of Orthopedic Surgeons (AAOS) Senior Achievement Award in recognition of his volunteer work for the AAOS and orthopedic community.

"Dr. Shea truly embodies the spirit of honoring the gift of tissue donation to help heal his patients," said Thomas Cycyota, AlloSource president and CEO. "His commitment to research and improving treatment methods using donated tissue is an inspiration to all of us at AlloSource. We admire his dedication to the profession of orthopedic surgery and to his patients."  

The award honors a physician who understands and embraces the use of donated human tissue in surgical applications. The award is named after Dr. Steven Gitelis, a highly regarded orthopedic surgeon and one of the founders of AlloSource.

About AlloSource
AlloSource is dedicated to advancing the science and use of transplantable allogeneic cells and tissue through pioneering research in regenerative therapies. The organization offers life-saving and life-enhancing solutions in orthopedic, spine, burn and wound procedures to help restore patient health and mobility. As a world leader in cell-based products, fresh cartilage tissue for joint repair and skin allografts to help heal severe burns, AlloSource's products bridge the proven science of allografts with the advanced technology of cells. The company is accredited by the American Association of Tissue Banks and is headquartered in Centennial, CO. For more information, please visit allosource.org.  

Media Contact
Megan Duggan
AlloSource
720. 382. 2766
[email protected] 

                                                                                       

SOURCE AlloSource


These press releases may also interest you

at 12:05
VirtualHealth is excited to share that its HELIOS platform was named the winner of a Bronze Stevie® Award in the Healthcare Technology Solution category in The 22nd Annual American Business Awards® today. More than 3,700 nominations were submitted...

at 12:02
On May 1, 2024, Toronto Public Health (TPH) will host Diverse Dialogues: Stigma & Breaking Barriers. The event will bring together distinguished speakers to explore the challenging and thought-provoking topic about how negative labels and biases...

at 11:56
As the demand for cosmetic procedures continues to rise, patients are seeking more advanced and effective options for achieving a youthful and rejuvenated appearance. In response to this, Dr. Ronald Demeo has introduced the Next Level Deep Plane Face...

at 11:50
Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company") today reported its 2023 consolidated annual financial results, as of December 31, 2023, and provided financial information (unaudited)...

at 11:34
At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided: Resolution in accordance with the Board's proposed dividend of SEK 1.00 per share for the financial year 2023. 29 April, 2024 was adopted as the...

at 11:25
TimelyCare, higher education's most trusted virtual health and well-being provider, has earned recognition as one of the World's Best Digital Health Companies by Newsweek, and has been awarded five Top Workplaces Awards for culture excellence....



News published on and distributed by: